GeneDx Holdings

WGS

Market cap $1.87B

SAN DIEGO, July 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, both dates inclusive (the “Class Period”), have until Monday, August 3, 2026 to seek appointment as lead plaintiff of the GeneDx class action lawsuit. Captioned Basma v.

NEW ORLEANS, July 16, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against GeneDx Holdings Corp. (NasdaqGS: WGS), if they purchased or otherwise acquired the Company's shares between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Connecticut.

Important Information Regarding Section 20(a) Individual Liability Claims Against GeneDx CEO and CFO for Alleged $33.42 Per-Share Investor Losses Tied to reimbursement weakness and underperformance of Fabric Genomics NEW YORK, July 16, 2026 /PRNewswire/ -- SueWallSt alerts investors in GeneDx Holdings Corp. (NASDAQ: WGS) that two senior executives are named as individual defendants in a securities class action covering purchases between April 16, 2025 and May 4, 2026. Find out if you could qualify to recover your losses or contact Joseph E.

SAN DIEGO--(BUSINESS WIRE)---- $WGS #GeneDx--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026. GeneDx Holdings Corp is a genomics company that provides genetic testing services for diagnosing pediatric and rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What are the allegation.

NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GeneDx Holdings Corp. ("GeneDx" or the "Company") (NASDAQ: WGS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds GeneDx Holdings Corp. (“WGS” or the “Company”) (NASDAQ: WGS) investors of the  August 3, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The GeneDx Holdings Class Action Lawsuit : Do you, or did you, own shares of GeneDx Holdings Corp. (NASDAQ: WGS)?

SAN FRANCISCO, July 16, 2026 /PRNewswire/ -- Hagens Berman (HBSS), a national leader in securities litigation, is actively investigating claims in a securities class action lawsuit against GeneDx Holdings (NASDAQ: WGS) and its executives, alleging defendants misled investors about the Fabric Genomics acquisition and synergy potential. The suit follows a devastating 49% stock collapse on May 5, 2026 in response to the company's disastrous Q1 2026 earnings report, including a $31.2 million impairment charge.

SAN DIEGO, July 15, 2026 /PRNewswire/ -- The law firm of  Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, all dates inclusive (the "Class Period"), have until Monday, August 3, 2026 to seek appointment as lead plaintiff of the GeneDx class action lawsuit. Captioned Basma v.

Did you buy WGS securities between April 16, 2025, and May 4, 2026? Affected WGS Investor Summary Who: GeneDx Holdings Corp. (NASDAQ: WGS) What: Securities fraud class action lawsuit filed Class Period: April 16, 2025 through May 4, 2026 Deadline to Seek Lead Plaintiff Status: August 3, 2026 Key Lawsuit Allegations: Material misstatements and/or omissions concerning the viability of the company's acquisition of Fabric Genomics Investor Action: Contact Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) for recovery options RADNOR, Pa.

SAN FRANCISCO, July 15, 2026 (GLOBE NEWSWIRE) -- Hagens Berman (HBSS), a national leader in securities litigation, is actively investigating claims in a securities class action lawsuit against GeneDx Holdings (NASDAQ: WGS) and its executives, alleging defendants misled investors about the Fabric Genomics acquisition and synergy potential. The suit follows a devastating 49% stock collapse on May 5, 2026 in response to the company's disastrous Q1 2026 earnings report, including a $31.2 million impairment charge.